Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Controlled Phase II Trial of Pre-operative Celecoxib Treatment in Breast Cancer

NCT01695226 is registered in ClinicalTrials.gov with Maastricht University Medical Center as lead sponsor.

NCT NCT01695226
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01695226 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Controlled Phase II Trial of Pre-operative Celecoxib Treatment in Breast Cancer
Lead sponsor
Maastricht University Medical Center
Phase
Phase 2
Overall status
Completed
Start date
February 29, 2004
Completion date
Not reported
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, breast neoplasms